Confronting multidrug-resistant tuberculosis
- PMID: 22670908
- DOI: 10.1056/NEJMe1204478
Confronting multidrug-resistant tuberculosis
Comment in
-
Multidrug-resistant tuberculosis.N Engl J Med. 2012 Nov 29;367(22):2154; author reply 2155-6. doi: 10.1056/NEJMc1210001. N Engl J Med. 2012. PMID: 23190229 Free PMC article. No abstract available.
-
Multidrug-resistant tuberculosis.N Engl J Med. 2012 Nov 29;367(22):2154-5; author reply 2155-6. doi: 10.1056/NEJMc1210001. N Engl J Med. 2012. PMID: 23190230 No abstract available.
-
Multidrug-resistant tuberculosis.N Engl J Med. 2012 Nov 29;367(22):2155; author reply 2155-6. doi: 10.1056/NEJMc1210001. N Engl J Med. 2012. PMID: 23190231 No abstract available.
Comment on
-
Delamanid for multidrug-resistant pulmonary tuberculosis.N Engl J Med. 2012 Jun 7;366(23):2151-60. doi: 10.1056/NEJMoa1112433. N Engl J Med. 2012. PMID: 22670901 Clinical Trial.
-
National survey of drug-resistant tuberculosis in China.N Engl J Med. 2012 Jun 7;366(23):2161-70. doi: 10.1056/NEJMoa1108789. N Engl J Med. 2012. PMID: 22670902
Similar articles
-
Multidrug-resistant tuberculosis.N Engl J Med. 2012 Nov 29;367(22):2154; author reply 2155-6. doi: 10.1056/NEJMc1210001. N Engl J Med. 2012. PMID: 23190229 Free PMC article. No abstract available.
-
Multidrug-resistant tuberculosis.N Engl J Med. 2012 Nov 29;367(22):2155; author reply 2155-6. doi: 10.1056/NEJMc1210001. N Engl J Med. 2012. PMID: 23190231 No abstract available.
-
Multidrug-resistant tuberculosis.N Engl J Med. 2012 Nov 29;367(22):2154-5; author reply 2155-6. doi: 10.1056/NEJMc1210001. N Engl J Med. 2012. PMID: 23190230 No abstract available.
-
Combined treatment of drug-resistant tuberculosis with bedaquiline and delamanid: a systematic review.Eur Respir J. 2018 Jul 4;52(1):1800934. doi: 10.1183/13993003.00934-2018. Print 2018 Jul. Eur Respir J. 2018. PMID: 29903862 No abstract available.
-
[Tuberculosis: new treatment options and updated recommendations].Dtsch Med Wochenschr. 2013 Apr;138(14):725-7. doi: 10.1055/s-0032-1332867. Epub 2013 Mar 26. Dtsch Med Wochenschr. 2013. PMID: 23533039 Review. German. No abstract available.
Cited by
-
Diagnostic accuracy of Xpert MTB/RIF for tuberculosis detection in different regions with different endemic burden: A systematic review and meta-analysis.PLoS One. 2017 Jul 14;12(7):e0180725. doi: 10.1371/journal.pone.0180725. eCollection 2017. PLoS One. 2017. PMID: 28708844 Free PMC article.
-
Xpert MTB/RIF assay for the diagnosis of rifampicin resistance in different regions: a meta-analysis.BMC Microbiol. 2019 Aug 5;19(1):177. doi: 10.1186/s12866-019-1516-5. BMC Microbiol. 2019. PMID: 31382894 Free PMC article. Review.
-
Targeting multidrug-resistant tuberculosis (MDR-TB) by therapeutic vaccines.Med Microbiol Immunol. 2013 Apr;202(2):95-104. doi: 10.1007/s00430-012-0278-6. Epub 2012 Nov 10. Med Microbiol Immunol. 2013. PMID: 23143437 Review.
-
Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.Cochrane Database Syst Rev. 2013 Jan 31;(1):CD009593. doi: 10.1002/14651858.CD009593.pub2. Cochrane Database Syst Rev. 2013. Update in: Cochrane Database Syst Rev. 2014 Jan 21;(1):CD009593. doi: 10.1002/14651858.CD009593.pub3. PMID: 23440842 Free PMC article. Updated.
-
Molecular characterisation of rifampicin-resistant Mycobacterium tuberculosis strains from Malawi.Afr J Lab Med. 2017 Mar 31;6(2):463. doi: 10.4102/ajlm.v6i2.463. eCollection 2017. Afr J Lab Med. 2017. PMID: 28879159 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources